Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-035596
Filing Date
2020-06-10
Accepted
2020-06-10 17:09:15
Documents
1
Period of Report
2020-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3890
  Complete submission text file 0001209191-20-035596.txt   5301
Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE CA 94085
Business Address
Kunkel Lori Anne (Reporting) CIK: 0001536368 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 20955420

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations